Categories Earnings, Health Care
Earnings Summary: CooperCompanies (COO) reports Q2 2023 financial results
Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the second quarter of 2023, reporting lower earnings despite an increase in revenues.
- Second-quarter revenue rose 6% year-over-year to $877.4 million; CooperVision revenue rose 6% and CooperSurgical revenue moved up 4%
- Net earnings per share, including special items, came in at $0.80, down 69% from last year’s earnings of $2.55
- Net income was $39.8 million in the April quarter, compared to $126.6 million in Q2 2022
- Adjusted earnings decreased to $3.08 per share in Q2 from $3.24 per share in the same period of last year
- The operating margin was 11%, lower than the 16% margin reported a year earlier
- Cash provided by operations totaled $124.2 million and free cash flow came in at $50.6 million
Most Popular
Infographic: Key metrics from Estee Lauder’s (EL) Q3 2024 earnings results
The Estee Lauder Companies Inc. (NYSE: EL) reported its third quarter 2024 earnings results today. Net sales were $3.94 billion, up 5% from the prior-year quarter. Organic sales increased 6%.
YUM Earnings: Key quarterly highlights from Yum! Brands’ Q1 2024 financial results
Yum! Brands, Inc. (NYSE: YUM) reported first quarter 2024 earnings results today. Total revenues decreased 3% year-over-year to $1.59 billion. Same-store sales declined 3%. Net income increased 5% to $314
Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined 44% to $3.1 billion, or $0.55 per share,
